US5166057A
(en)
*
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US20060019350A1
(en)
*
|
1989-08-28 |
2006-01-26 |
Peter Palese |
Recombinant negative strand RNA virus expression system and vacccines
|
US5854037A
(en)
*
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
US5840520A
(en)
*
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
US6887699B1
(en)
*
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
BR9106747A
(pt)
*
|
1990-08-14 |
1993-07-20 |
Isis Pharmaceuticals Inc |
Oligonucleotideo ou analogo de oligonucleotideo e processo para tratamento de um animal suspeito de estar infectado por virus da influenza
|
US5837261A
(en)
*
|
1990-09-25 |
1998-11-17 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
US7374768B1
(en)
*
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
US5665362A
(en)
*
|
1990-09-25 |
1997-09-09 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
EP0492920A1
(en)
*
|
1990-12-24 |
1992-07-01 |
Merck & Co. Inc. |
Chimaeric influenza-HIV vaccine
|
CA2084180A1
(en)
*
|
1991-12-11 |
1993-06-12 |
Paul P. Hung |
Expression of specific immunogens using viral antigens
|
CA2118234A1
(en)
*
|
1992-04-14 |
1993-10-28 |
Peter Palese |
Genetically engineered attenuated viruses
|
WO1994013837A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Lionel Resnick |
Method for detecting a virus
|
JPH08511424A
(ja)
*
|
1993-06-11 |
1996-12-03 |
パリーズ,ピーター |
高収量性インフルエンザウイルス
|
US7344722B1
(en)
*
|
1993-06-29 |
2008-03-18 |
The Regents Of The University Of Michigan |
Cold-adapted influenza virus
|
AU2359195A
(en)
*
|
1994-04-19 |
1995-11-10 |
Thomas Jefferson University |
Viral ribonucleocapsid as an immunological enhancer
|
ATE245199T1
(de)
*
|
1994-05-20 |
2003-08-15 |
Sinai School Medicine |
Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen
|
ATE257175T1
(de)
*
|
1994-07-18 |
2004-01-15 |
Conzelmann Karl Klaus Prof Dr |
Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
|
US5716821A
(en)
*
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
EP0704533A1
(en)
*
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
|
US7465574B2
(en)
*
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US5597697A
(en)
*
|
1994-09-30 |
1997-01-28 |
Diamond; Paul |
Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases
|
US20030054505A1
(en)
*
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
WO1996010633A1
(en)
*
|
1994-09-30 |
1996-04-11 |
Aviron |
Chimeric influenza virus and electroporation method
|
WO1996010400A1
(en)
*
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
US5753489A
(en)
*
|
1994-11-10 |
1998-05-19 |
Immuno Ag |
Method for producing viruses and vaccines in serum-free culture
|
US6146873A
(en)
*
|
1994-11-10 |
2000-11-14 |
Baxter Aktiengesellschaft |
Production of orthomyxoviruses in monkey kidney cells using protein-free media
|
US5698433A
(en)
*
|
1994-11-10 |
1997-12-16 |
Immuno Ag |
Method for producing influenza virus and vaccine
|
US5756341A
(en)
*
|
1994-11-10 |
1998-05-26 |
Immuno Ag |
Method for controlling the infectivity of viruses
|
DE19503082A1
(de)
*
|
1995-02-01 |
1996-08-08 |
Univ Ludwigs Albert |
Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
|
US7153510B1
(en)
*
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
DE69510207T3
(de)
*
|
1995-08-09 |
2007-02-15 |
Schweiz. Serum- & Impfinstitut Bern |
Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
|
EP0864645B9
(en)
|
1995-10-31 |
2006-03-22 |
Dnavec Research Inc. |
Negative-strand rna virus vector having autonomously replicating activity
|
EP0863202B1
(en)
*
|
1995-11-01 |
2010-06-09 |
Dnavec Research Inc. |
Recombinant sendai virus
|
ES2109189B1
(es)
*
|
1996-03-14 |
1998-05-16 |
Iberica Cyanamid |
Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.
|
AU2749297A
(en)
*
|
1996-05-01 |
1997-11-19 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins
|
US6022863A
(en)
*
|
1996-05-21 |
2000-02-08 |
Yale University |
Regulation of gene expression
|
US5939262A
(en)
*
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
US5677124A
(en)
*
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
WO1998012332A1
(en)
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US20030125280A1
(en)
*
|
1996-12-03 |
2003-07-03 |
Medical University Of South Carolina |
Tissue specific and target RNA-specific ribozymes as antimicrobial therapeutics against microbial pathogens
|
US6884414B1
(en)
|
1997-04-30 |
2005-04-26 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
|
ES2289782T3
(es)
|
1997-05-07 |
2008-02-01 |
The Cleveland Clinic Foundation |
Clon infeccioso para el virus parainfluenza de tipo 3 humano.
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US6872518B2
(en)
|
1997-09-22 |
2005-03-29 |
University Of Rochester |
Methods for selecting polynucleotides encoding T cell epitopes
|
US6830748B1
(en)
*
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
ID26107A
(id)
*
|
1998-02-27 |
2000-11-23 |
Pamgene Bv |
Metoda untuk amplifikasi tak spesifik dari asam nukleat
|
CA2325564A1
(en)
*
|
1998-03-27 |
1999-10-07 |
Cytos Biotechnology Ag |
Inducible alphaviral gene expression system
|
BR9910089A
(pt)
|
1998-05-01 |
2004-06-08 |
Chiron Corp |
Composições e antìgenos de neisseria meningitidis
|
US6573079B1
(en)
|
1998-06-12 |
2003-06-03 |
Mount Sinai School Of Medicine Of New York University |
Methods and interferon deficient substrates for the propagation of viruses
|
DK1098961T3
(da)
|
1998-06-12 |
2008-05-26 |
Andrej Y Dr Egorov |
Gensplejsede svækkede vira, der inducerer interferon
|
EP1088086A4
(en)
*
|
1998-06-24 |
2003-01-08 |
Musc Found For Res Dev |
RIBOZYMES SPECIFIC TO TISSUE AND TARGET RNA
|
WO2000006205A1
(en)
*
|
1998-07-29 |
2000-02-10 |
Invitrogen Corporation |
Regulated expression of recombinant proteins using rna viruses
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US6720415B2
(en)
*
|
1998-12-02 |
2004-04-13 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
US7326542B2
(en)
*
|
1998-12-02 |
2008-02-05 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
EP1035209A1
(en)
*
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US8715940B2
(en)
*
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
WO2000061804A1
(en)
*
|
1999-04-14 |
2000-10-19 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
RU2245366C2
(ru)
|
1999-04-30 |
2005-01-27 |
Чирон С.Р.Л. |
Антиген neisseria, кодирующая его нуклеиновая кислота, их использование
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
AU6454700A
(en)
*
|
1999-07-30 |
2001-02-19 |
Isis Innovation Limited |
Attenuated influenza virus useful as vaccine
|
EP2275552B1
(en)
|
1999-10-29 |
2015-09-09 |
GlaxoSmithKline Biologicals SA |
Neisserial antigenic peptides
|
AU1647501A
(en)
|
1999-12-10 |
2001-06-18 |
Cytos Biotechnology Ag |
Replicon based activation of endogenous genes
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
US6764685B1
(en)
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US20030194696A1
(en)
*
|
2000-03-28 |
2003-10-16 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides of interest
|
WO2001072995A2
(en)
*
|
2000-03-28 |
2001-10-04 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucletides
|
WO2001077394A1
(en)
*
|
2000-04-10 |
2001-10-18 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
BRPI0110607B8
(pt)
*
|
2000-04-28 |
2021-05-25 |
St Jude Childrens Res Hospital |
sistema baseado em plasmídeos, método para produzir um vírion de vírus com fita rna negativa, método para produzir um vírion orthomyxoviridae, método para produzir um vírion influenza, método para produzir um vírion influenzapatogênico, método para preparar uma vacina específica de vírus rna de fita negativa e método para gerar um vírus rna de fita negativa atenuado
|
IES20010462A2
(en)
*
|
2000-05-12 |
2001-11-14 |
Cyril John Higgins |
Use of the world wide web
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
KR20090006239A
(ko)
*
|
2000-06-23 |
2009-01-14 |
와이어쓰 홀딩스 코포레이션 |
cDNA로 부터 개 홍역 바이러스의 구출
|
NZ523831A
(en)
*
|
2000-07-13 |
2005-10-28 |
Invitrogen Corp |
Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
MXPA03003690A
(es)
|
2000-10-27 |
2004-05-05 |
Chiron Spa |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
US20040209263A1
(en)
*
|
2000-12-07 |
2004-10-21 |
Clawson Gary A. |
Selection of catalytic nucleic acids targeted to infectious agents
|
WO2002098457A2
(en)
*
|
2001-01-17 |
2002-12-12 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
US8715922B2
(en)
*
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
NZ527221A
(en)
|
2001-01-19 |
2006-09-29 |
Vironovative B |
A negative-sense single stranded RNA virus causing respiratory tract illness in susceptible mammals
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
WO2002083896A2
(en)
|
2001-04-17 |
2002-10-24 |
Institut Pasteur |
Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
|
GB0123276D0
(en)
|
2001-09-27 |
2001-11-21 |
Imp College Innovations Ltd |
Uses of agents that bind immune-system components
|
ES2312649T3
(es)
|
2001-12-12 |
2009-03-01 |
Novartis Vaccines And Diagnostics S.R.L. |
Inmunizacion frente a chlamydia trachomatis.
|
US7820435B2
(en)
*
|
2002-02-06 |
2010-10-26 |
Expression Technologies Inc. |
De novo synthesized plasmid, methods of making and use thereof
|
US7226774B2
(en)
*
|
2002-02-13 |
2007-06-05 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
KR101011410B1
(ko)
*
|
2002-02-13 |
2011-01-28 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
US8709442B2
(en)
*
|
2002-02-21 |
2014-04-29 |
Icahn School Of Medicine At Mount Sinai |
Recombinant negative strand virus RNA expression systems and vaccines
|
JP4553588B2
(ja)
|
2002-02-21 |
2010-09-29 |
メディミューン,エルエルシー |
メタニューモウイルス(metapneumovirus)株と、ワクチン製剤でのおよび抗原配列発現用ベクターとしてのその使用
|
WO2003091401A2
(en)
|
2002-04-26 |
2003-11-06 |
Medimmune Vaccines, Inc. |
Multi plasmid system for the production of influenza virus
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
US7563882B2
(en)
|
2002-06-10 |
2009-07-21 |
University Of Rochester |
Polynucleotides encoding antibodies that bind to the C35 polypeptide
|
TW200501985A
(en)
*
|
2002-07-25 |
2005-01-16 |
Medimmune Inc |
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
|
EP1572108A4
(en)
*
|
2002-09-27 |
2008-09-17 |
Medimmune Vaccines Inc |
FUNCTIONAL MUTATIONS OF RSV (RESPIRATORY SYNCYTIAL VIRUS)
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
EP2279746B1
(en)
|
2002-11-15 |
2013-10-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Surface proteins in neisseria meningitidis
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
JP2006524511A
(ja)
*
|
2003-04-25 |
2006-11-02 |
メッドイミューン バクシーンズ,インコーポレイティド |
メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン
|
JP2007525178A
(ja)
|
2003-04-25 |
2007-09-06 |
メッドイミューン バクシーンズ,インコーポレイティド |
メタニューモウイルス株、そのワクチン製剤における用途、抗原性配列の発現のためのベクターとしての用途、並びにウイルス増殖方法
|
WO2004112831A2
(en)
*
|
2003-05-28 |
2004-12-29 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines and gene therapy
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
US7696406B2
(en)
*
|
2003-07-03 |
2010-04-13 |
Board Of Trustees Operating Michigan State University |
Expression of a recombinant transgene
|
EP2311994A1
(en)
*
|
2003-08-01 |
2011-04-20 |
Life Technologies Corporation |
Compositions and methods for preparing short RNA molecules and other nucleic acids
|
US7807646B1
(en)
*
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7763592B1
(en)
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
ES2345492T3
(es)
*
|
2003-12-23 |
2010-09-24 |
Medimmune, Llc |
Sistema multiplasmido para la produccion del virus de la gripe.
|
JP5600375B2
(ja)
|
2004-03-09 |
2014-10-01 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
インフルエンザウイルスワクチン
|
PT1736541E
(pt)
|
2004-03-29 |
2013-01-31 |
Galpharma Co Ltd |
Nova proteína galectina 9 modificada e sua utilização
|
WO2005116260A2
(en)
*
|
2004-05-25 |
2005-12-08 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
ES2694123T3
(es)
*
|
2004-06-01 |
2018-12-18 |
Icahn School Of Medicine At Mount Sinai |
Virus de la gripe porcina modificado por ingeniería genética y usos de los mismos
|
EP1812564A2
(en)
*
|
2004-11-11 |
2007-08-01 |
Solvay Pharmaceuticals B.V. |
Defective influenza virus particles
|
US7968101B2
(en)
|
2004-11-19 |
2011-06-28 |
Wisconsin Alumni Research Foundation |
Recombinant influenza vectors with tandem transcription units
|
AU2011204881B2
(en)
*
|
2004-12-24 |
2012-04-19 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
KR101272487B1
(ko)
*
|
2004-12-24 |
2013-06-07 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
인플루엔자 바이러스의 구제
|
US8137676B2
(en)
*
|
2005-02-15 |
2012-03-20 |
Mount Sinai School Of Medicine |
Genetically engineered equine influenza virus and uses thereof
|
EP2441471B1
(en)
|
2005-03-08 |
2014-10-08 |
MedImmune, LLC |
Reassortant influenza viruses
|
CA2600484A1
(en)
*
|
2005-03-10 |
2006-09-21 |
Medimmune Vaccines, Inc. |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
JP4976376B2
(ja)
*
|
2005-04-08 |
2012-07-18 |
メディミューン,エルエルシー |
哺乳動物メタニューモウイルスに対する抗体
|
EP3479844B1
(en)
|
2005-04-15 |
2023-11-22 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
US8217147B2
(en)
|
2005-08-10 |
2012-07-10 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
US9119810B2
(en)
*
|
2005-11-18 |
2015-09-01 |
Rutgers, The State University Of New Jersey |
Compositions and vaccines against influenza A and influenza B infections
|
PT2251034T
(pt)
|
2005-12-02 |
2018-05-22 |
Icahn School Med Mount Sinai |
Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações
|
US9254318B2
(en)
|
2006-03-31 |
2016-02-09 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
DK2016194T3
(da)
|
2006-04-19 |
2015-06-15 |
Medimmune Llc |
Fremgangsmåder og sammensætninger til ekspression af viralt negativ-sense-rna i hundeceller
|
US20110206692A1
(en)
|
2006-06-09 |
2011-08-25 |
Novartis Ag |
Conformers of bacterial adhesins
|
US7507411B2
(en)
*
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
EP2049662A4
(en)
*
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
|
CA2659267C
(en)
*
|
2006-08-09 |
2016-12-13 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
WO2008105931A2
(en)
|
2006-09-15 |
2008-09-04 |
Medimmune Vaccines, Inc. |
Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
|
US8052968B2
(en)
|
2006-10-16 |
2011-11-08 |
Genelux Corporation |
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
|
WO2008147496A2
(en)
*
|
2007-05-04 |
2008-12-04 |
Warf - Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
JP5666905B2
(ja)
*
|
2007-06-18 |
2015-02-12 |
メディミューン,エルエルシー |
ヘマグルチニンポリペプチド中に変化を有するインフルエンザbウイルス
|
CN101821288A
(zh)
|
2007-06-21 |
2010-09-01 |
宏观基因有限公司 |
共价双抗体及其用途
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
SG192501A1
(en)
|
2008-07-11 |
2013-08-30 |
Medimmune Llc |
Influenza hemagglutinin and neuraminidase variants
|
CN102215865B
(zh)
|
2008-09-24 |
2013-10-30 |
米迪缪尼有限公司 |
病毒纯化方法
|
CN106432503B
(zh)
|
2008-12-19 |
2020-03-06 |
宏观基因有限公司 |
共价双抗体及其用途
|
WO2010091262A1
(en)
|
2009-02-05 |
2010-08-12 |
Mount Sinai School Of Medicine Of New York University |
Chimeric newcastle disease viruses and uses thereof
|
WO2010093537A2
(en)
*
|
2009-02-12 |
2010-08-19 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
EP2413962A1
(en)
|
2009-03-30 |
2012-02-08 |
Mount Sinai School of Medicine |
Influenza virus vaccines and uses thereof
|
US9217157B2
(en)
|
2009-07-27 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Recombinant influenza viruses and uses thereof
|
JP5845180B2
(ja)
|
2009-07-30 |
2016-01-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルス及びそれらの使用
|
RU2583298C2
(ru)
|
2009-10-07 |
2016-05-10 |
Макродженикс, Инк. |
ПОЛИПЕПТИДЫ, СОДЕРЖАЩИЕ Fc-УЧАСТОК, КОТОРЫЕ ДЕМОНСТРИРУЮТ ПОВЫШЕННУЮ ЭФФЕКТОРНУЮ ФУНКЦИЮ БЛАГОДАРЯ ИЗМЕНЕНИЯМ СТЕПЕНИ ФУКОЗИЛИРОВАНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
JP2013507990A
(ja)
|
2009-10-26 |
2013-03-07 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
KR20130075732A
(ko)
|
2010-03-30 |
2013-07-05 |
마운트 시나이 스쿨 오브 메디슨 |
인플루엔자 바이러스 백신 및 이의 용도
|
WO2011156273A1
(en)
*
|
2010-06-06 |
2011-12-15 |
Mount Sinai School Of Medicine |
Recombinant rna viruses and uses thereof
|
JP5964300B2
(ja)
|
2010-08-02 |
2016-08-03 |
マクロジェニクス,インコーポレーテッド |
共有結合型ダイアボディおよびその使用
|
NZ618016A
(en)
|
2011-05-21 |
2015-05-29 |
Macrogenics Inc |
Deimmunized serum-binding domains and their use for extending serum half-life
|
US20130189303A1
(en)
|
2011-08-02 |
2013-07-25 |
Yan Zhou |
Recombinant swine influenza virus and uses thereof
|
EP2747778B1
(en)
|
2011-08-26 |
2017-12-06 |
Wisconsin Alumni Research Foundation |
Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
|
EP2758075B1
(en)
|
2011-09-20 |
2023-05-03 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
SG11201401137TA
(en)
|
2011-10-07 |
2014-07-30 |
Medimmune Llc |
Influenza hemagglutinin variants
|
AU2013362935B2
(en)
|
2012-12-18 |
2018-10-04 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
BR112015021414B1
(pt)
|
2013-03-14 |
2020-11-10 |
Icahn School Of Medicine At Mount Sinai |
vírus da doença newcastle e seus usos
|
CA2953917C
(en)
|
2013-07-01 |
2021-10-19 |
The Research Foundation For The State University Of New York |
Ship inhibition to combat obesity
|
US9950057B2
(en)
|
2013-07-15 |
2018-04-24 |
Wisconsin Alumni Research Foundation (Warf) |
High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
|
WO2015127501A1
(en)
|
2014-02-27 |
2015-09-03 |
Viralytics Limited |
Combination method for treatment of cancer
|
EP3157529B1
(en)
|
2014-06-17 |
2021-08-04 |
The Research Foundation for The State University of New York |
Ship inhibition to induce activation of natural killer cells
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
CN107208071B
(zh)
*
|
2014-11-13 |
2021-11-30 |
港大科桥有限公司 |
用于流感病毒的减弱活疫苗
|
US10736956B2
(en)
|
2015-01-23 |
2020-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
EP3261664A1
(en)
|
2015-02-26 |
2018-01-03 |
Boehringer Ingelheim Vetmedica GmbH |
Bivalent swine influenza virus vaccine
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
US10973903B2
(en)
|
2015-08-20 |
2021-04-13 |
University Of Rochester |
NS1 truncated virus for the development of canine influenza vaccines
|
WO2017031404A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
|
US10548966B2
(en)
|
2015-08-20 |
2020-02-04 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
EP3341018A1
(en)
|
2015-08-28 |
2018-07-04 |
Wisconsin Alumni Research Foundation |
Generation of infectious influenza viruses from virus-like particles
|
CN109477074B
(zh)
|
2016-02-19 |
2023-01-24 |
威斯康星旧生研究基金会 |
用于疫苗开发的改进的乙型流感病毒复制
|
CA3026256A1
(en)
|
2016-06-03 |
2017-12-07 |
University Of Rochester |
Equine influenza virus live-attenuated vaccines
|
WO2017218624A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
MX2020008927A
(es)
|
2018-02-27 |
2021-01-08 |
Univ Rochester |
Vacuna contra la influenza atenuada viva multivalente para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
JP2022527235A
(ja)
|
2019-01-23 |
2022-06-01 |
義裕 河岡 |
インフルエンザウイルスにおける付加的遺伝子に遺伝的安定性を付与する突然変異
|
JP2022522112A
(ja)
|
2019-02-08 |
2022-04-14 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヒト化細胞系
|
MX2021010343A
(es)
|
2019-02-27 |
2022-01-18 |
Univ Rochester |
Vacuna para la influenza multivalente con virus vivo atenuado para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
|
US11390649B2
(en)
|
2019-05-01 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
JP2022551805A
(ja)
|
2019-08-27 |
2022-12-14 |
ウィスコンシン アルムニ リサーチ ファンデイション |
卵内複製のための安定化されたhaを持つ組換えインフルエンザウイルス
|